Storia in 6 fonti

What's Going on With Pfizer Stock Tuesday? - Pfizer (NYSE:PFE)

Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B. Get the key earnings takeaways.

Raccontata da

economictimes.indiatimes.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo13 h fa

What's Going on With Pfizer Stock Tuesday? - Pfizer (NYSE:PFE)

Pfizer beat Q2 (EPS 77¢ vs 69¢) and raised FY2026 guidance to $60.5–62.5B. Strategic acquisitions in oncology/obesity signal post-COVID shift; Metsera approval target 2028 exemplifies pivot toward specialty therapeutics and emerging clinical markets.

originale

Timeline cronologica

martedì 4 agosto 2026·benzinga.com
Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analy
Pfizer (PFE) will release Q2 earnings on Aug. 4, expected to report lower EPS of 68 cents and revenue at $14.39B. Stock rose 0.1% on Monday.
martedì 4 agosto 2026·swissinfo.ch
Pfizer Raises Sales Guidance on High Demand for Older Drugs
(Bloomberg) -- Pfizer Inc. raised the midpoint of its 2026 sales forecast after reporting strong second-quarter demand for older medicines.

What's Going on With Pfizer Stock Tuesday? - Pfizer (NYSE:PFE)

Confronto fonti

What's Going on With Pfizer Stock Tuesday? - Pfizer (NYSE:PFE)

Timeline cronologica

Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analy

Pfizer Raises Sales Guidance on High Demand for Older Drugs

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts

Pfizer Raises Sales Guidance on High Demand for Older Drugs

Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts

Pfizer raises sales guidance on high demand for older drugs

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts

Pfizer raises sales guidance on high demand for older drugs

Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings - Pfizer (NYSE:PFE), SU Group Holdings (NASDAQ

Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts

What's Going on With Pfizer Stock Tuesday? - Pfizer (NYSE:PFE)